Age-related macular degeneration (AMD) is one of the leading causes of vision loss among older adults. It affects the macula, the central part of the retina responsible for sharp, detailed vision. Although there is no cure for AMD, recent advances in treatment have expanded the options available for slowing disease progression and helping preserve vision in eligible patients.
AMD develops as changes occur in the macula over time.
Common symptoms may include:
Early diagnosis can help guide appropriate treatment.
Recent advances have introduced therapies for certain forms of geographic atrophy, an advanced stage of dry AMD.
Depending on individual circumstances, ophthalmologists may discuss:
These treatments are intended to slow the progression of geographic atrophy and may not restore vision that has already been lost.
For wet AMD, anti-VEGF medications remain the standard treatment.
These therapies work by helping reduce the growth of abnormal blood vessels beneath the retina.
Treatment commonly involves:
Treatment frequency varies according to the medication and individual response.
For some people with intermediate or advanced AMD, an ophthalmologist may recommend nutritional supplements based on the AREDS2 formula.
These supplements commonly contain:
AREDS2 supplements are not appropriate for everyone and should be used according to professional guidance.
Healthy lifestyle choices may help support long-term eye health.
Common recommendations include:
These habits complement medical treatment rather than replace it.
People with AMD often undergo regular evaluations that may include:
Routine follow-up helps detect changes that may require treatment.
Researchers continue to study promising therapies, including:
Many of these approaches remain under clinical investigation.
Prompt medical evaluation is recommended if there is:
Early treatment is particularly important for wet AMD.
Advances in the treatment of macular degeneration have provided new options for managing both dry and wet forms of the disease. Complement inhibitor therapies for eligible patients with geographic atrophy and anti-VEGF medications for wet AMD have expanded the tools available to ophthalmologists. Regular eye examinations, timely diagnosis, appropriate treatment, and healthy lifestyle habits remain essential for preserving vision and slowing disease progression.